Betamethasone Dipropionate vs Rituximab

## Betamethasone Dipropionate vs Rituximab: Overview

This comparison examines the pharmacological differences between **Betamethasone Dipropionate** and **Rituximab**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Betamethasone Dipropionate — N/A; Rituximab — 22 days.

## Chemical Properties

**Type**: Betamethasone Dipropionate — Small molecule; Rituximab — Antibody.